KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Petmed Express (PETS) Net Income towards Common Stockholders (2016 - 2025)

Petmed Express has reported Net Income towards Common Stockholders over the past 16 years, most recently at -$10.6 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 1322.24% year-over-year to -$10.6 million; the TTM value through Dec 2025 reached -$64.9 million, down 20059.69%, while the annual FY2025 figure was -$6.3 million, 15.98% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$10.6 million at Petmed Express, down from -$8.5 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $6.5 million in Q3 2021 and troughed at -$34.2 million in Q2 2025.
  • A 5-year average of -$2.2 million and a median of -$42000.0 in 2021 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: surged 2421.88% in 2022 and later tumbled 2201.39% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at $4.4 million in 2021, then crashed by 104.84% to -$212000.0 in 2022, then crashed by 864.62% to -$2.0 million in 2023, then soared by 63.72% to -$742000.0 in 2024, then plummeted by 1322.24% to -$10.6 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for PETS at -$10.6 million in Q4 2025, -$8.5 million in Q3 2025, and -$34.2 million in Q2 2025.